Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 6 , Pages 802-808 , November 2011

Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models

  • Yingming Li, M.D.

      Affiliations

    • Department of Urology, University of Minnesota, Minneapolis, MN 55455, USA
    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    • Y.L. and R.A.S. contributed equally to this work.
    • ,
  • Robert A. Sikes, Ph.D.

      Affiliations

    • Department of Cell Biology, University of Delaware, Newark, DE 19716, USA
    • Y.L. and R.A.S. contributed equally to this work.
    • ,
  • Bahaa S. Malaeb, M.D.

      Affiliations

    • Department of Urology, University of Minnesota, Minneapolis, MN 55455, USA
    • ,
  • Fan Yeung, Ph.D.

      Affiliations

    • Molecular Urology and Therapeutics Program, Department of Urology, University of Virginia, Charlottesville, VA 22904, USA
    • ,
  • Andrew Law, M.S.

      Affiliations

    • Molecular Urology and Therapeutics Program, Department of Urology, University of Virginia, Charlottesville, VA 22904, USA
    • ,
  • Sarah E. Graham, B.A.

      Affiliations

    • Molecular Urology and Therapeutics Program, Department of Urology, University of Virginia, Charlottesville, VA 22904, USA
    • ,
  • Min Pei, B.S.

      Affiliations

    • Department of Urology, University of Minnesota, Minneapolis, MN 55455, USA
    • ,
  • Chinghai Kao, Ph.D.

      Affiliations

    • Department of Urology, Indiana University, Indianapolis, IN 46202, USA
    • ,
  • Joel Nelson, M.D.

      Affiliations

    • Department of Urology, University of Pittsburgh, Pittsburgh, PA 15260, USA
    • ,
  • Kenneth S. Koeneman, M.D.

      Affiliations

    • Department of Urology, University of Minnesota, Minneapolis, MN 55455, USA
    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    • Corresponding Author InformationCorresponding author. Tel.: 612-625-6401; fax: 612-6260428
    • K.S.K. was financially supported by an AFUD scholarship and NIH T32 training grant.
    • ,
  • Leland W.K. Chung, Ph.D.

      Affiliations

    • Emory Winship Cancer Institute, Atlanta, GA 30322, USA

Received 17 August 2009 ,Revised 24 September 2009 ,Accepted 29 September 2009.

References 

  1. Mintz E, Smith G. Autopsy findings in 100 cases of prostate cancer. N Engl J Med. 1934;211:479–487
  2. Franks L. The spread of prostate cancer. J Pathol Bacteriol. 1956;72:603–611
  3. Harada M, Iida M, Yamaguchi M, et al. Analysis of bone metastasis of prostatic adenocarcinoma in 137 autopsy cases. Adv Exp Med Biol. 1992;324:173–182
  4. Bubendorf L, Schopfer A, Wagner U, et al. Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients. Hum Pathol. 2000;31:578–583
  5. Batson O. The function of vertebral veins and their role in the spread of metastasis. Ann Surg. 1942;112:138–149
  6. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–573
  7. Koeneman KS, Yeung F, Chung LW. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate. 1999;39:246–261
  8. Sikes RA, Nicholson BE, Koeneman KS, et al. Cellular interactions in the tropism of prostate cancer to bone. Int J Cancer. 2004;110:497–503
  9. Gleave M, Hsieh JT, Gao CA, et al. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res. 1991;51:3753–3761
  10. Wu HC, Hsieh JT, Gleave ME, et al. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells. Int J Cancer. 1994;57:406–412
  11. Thalmann GN, Anezinis PE, Chang SM, et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res. 1994;54:2577–2581
  12. Diduch DR, Coe MR, Joyner C, et al. Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization. J Bone Joint Surg Am. 1993;75:92–105
  13. Thalmann GN, Sikes RA, Wu TT, et al. LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis. Prostate. 2000;44:91–103
  14. Cui Q, Wang GJ, Balian G. Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice. Connect Tissue Res. 2000;41:45–56
  15. Cui Q, Wang GJ, Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am. 1997;79:1054–1063
  16. Yeung F, Li X, Ellett J, et al. Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells. J Biol Chem. 2000;275:40846–40855
  17. Lang SH, Miller WR, Habib FK. Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow. Prostate. 1995;27:287–293
  18. Fizazi K, Yang J, Peleg S, et al. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Clin Cancer Res. 2003;9:2587–2597
  19. Ritchie CK, Andrews LR, Thomas KG, et al. The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: Implications for the development of metastatic disease. Endocrinology. 1997;138:1145–1150
  20. Barrett JM, Mangold KA, Jilling T, et al. Bidirectional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture. Prostate. 2005;64:75–82
  21. Andersen H, Jensen ON, Moiseeva EP, et al. A proteome study of secreted prostatic factors affecting osteoblastic activity: Galectin-1 is involved in differentiation of human bone marrow stromal cells. J Bone Miner Res. 2003;18:195–203
  22. Martinez J, Silva S, Santibanez JF. Prostate-derived soluble factors block osteoblast differentiation in culture. J Cell Biochem. 1996;61:18–25
  23. Zhau HE, Li CL, Chung LW. Establishment of human prostate carcinoma skeletal metastasis models. Cancer. 2000;88(12 Suppl):2995–3001
  24. Fu Z, Dozmorov IM, Keller ET. Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells. Prostate. 2002;51:10–20
  25. Cohen P, Graves HC, Peehl DM, et al. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 1992;75:1046–1053
  26. Cohen P, Peehl DM, Graves HC, et al. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol. 1994;142:407–415
  27. Plymate SR, Rosen CJ, Paulsen CA, et al. Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract. J Clin Endocrinol Metab. 1996;81:618–624
  28. Koistinen H, Paju A, Koistinen R, et al. Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3. Prostate. 2002;50:112–118
  29. Doherty A, Smith G, Banks L, et al. Correlation of the osteoblastic phenotype with prostate-specific antigen expression in metastatic prostate cancer: Implications for paracrine growth. J Pathol. 1999;188:278–281
  30. Yonou H, Aoyagi Y, Kanomata N, et al. Prostate-specific antigen induces osteoplastic changes by an autonomous mechanism. Biochem Biophys Res Commun. 2001;289:1082–1087
  31. Guo Y, Pili R, Passaniti A. Regulation of prostate-specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrotestosterone, and extracellular matrix. Prostate. 1994;24:1–10
  32. Gurova KV, Roklin OW, Krivokrysenko VI, et al. Expression of prostate specific antigen (PSA) is negatively regulated by p53. Oncogene. 2002;21:153–157
  33. Noguchi M, Stamey TA, McNeal JE, et al. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. J Urol. 2000;164:1596–1600
  34. Shariat SF, Lamb DJ, Kattan MW, et al. Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. J Clin Oncol. 2002;20:833–841
  35. Shariat SF, Gottenger E, Nguyen C, et al. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. Cancer Res. 2002;62:5974–5979
  36. Dillioglugil O, Leibman BD, Kattan MW, et al. Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology. 1997;50:93–99
  37. Leibman BD, Dillioglugil O, Wheeler TM, et al. Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level. Cancer. 1995;76:2530–2534
  38. Safa AA, Reese DM, Carter DM, et al. Undetectable serum prostate-specific antigen associated with metastatic prostate cancer: A case report and review of the literature. Am J Clin Oncol. 1998;21:323–326
  39. Akimoto S, Furuya Y, Akakura K, et al. Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: Comparison with prostatic acid phosphatase and alkaline phosphatase. Int J Urol. 1997;4:572–575
  40. Cheville JC, Tindall D, Boelter C, et al. Metastatic prostate carcinoma to bone: Clinical and pathologic features associated with cancer-specific survival. Cancer. 2002;95:1028–1036
  41. Aihara M, Lebovitz RM, Wheeler TM, et al. Prostate specific antigen and Gleason grade: An immunohistochemical study of prostate cancer. J Urol. 1994;151:1558–1564

☆ This work was supported in part by NIH grants CA63341 and CA63863.

PII: S1078-1439(09)00297-X

doi: 10.1016/j.urolonc.2009.09.016

Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 6 , Pages 802-808 , November 2011

Article Tools

* Image Usage & Resolution